Unknown

Dataset Information

Profiling the most elderly parkinson's disease patients: Does age or disease duration matter?


ABSTRACT:

Background

Despite our ageing populations, elderly patients are underrepresented in clinical research, and ageing research is often separate from that of Parkinson's disease (PD). To our knowledge, no previous study has focused on the most elderly ('old-old', age ≥ 85 years) patients with PD to reveal how age directly influences PD clinical progression.

Objective

We compared the clinical characteristics and pharmacological profiles, including complications of levodopa treatment, disease progression, disabilities, and comorbidities of the old-old with those of comparable younger ('young-old', age 60-75 years) PD patients. In addition, within the old-old group, we compared those with a short disease duration (< 10 years at the time of diagnosis) to those with a long disease du

SUBMITTER: Virameteekul S 

PROVIDER: S-EPMC8694485 | biostudies-literature | 2021

REPOSITORIES: biostudies-literature